跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HY-C
首页
药物
HY-C
HY-C
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
Process for the preparation of montelukast
EP 1693368 A1
申请人: CHEMI SPA
优先权: 2005
EP
US
3 件公开
PROTAC DEGRADERS OF MLLT1 AND/OR MLLT3
EP 4428134 A1
申请人: DARK BLUE THERAPEUTICS LTD
优先权: 2023
CN
EP
2 件公开
WO 2025262295 A1
申请人: DARK BLUE THERAPEUTICS LTD
优先权: 2024
WO
2 件公开
EP 4667467 A1
申请人: DARK BLUE THERAPEUTICS LTD
优先权: 2024
EP
EP 4667466 A1
申请人: DARK BLUE THERAPEUTICS LTD
优先权: 2024
EP
USE OF FLUORINATED SOLVENTS NON-VOLATILE AT ROOM TEMPERATURE IN COSMETIC OR PHARMACEUTICAL PRODUCTS
WO 02051378 A1
申请人: EXTRACTIVE S A
优先权: 2000
WO
Composition of the dyeing of human hair
US 2004139561 A1
申请人: KPSS KAO GMBH
优先权: 2002
US
C8, c8' linked 5-oxo-1,2,3,11a-tetrahydro-5h-pyrrolo[2,1-c][1,4] benzodiazepine dimers with 1h-pyrrole-dicarboxylic acid amide linkers and oligomeric analogs therof as well as related compounds for the treatment of proliferative diseases
US 2007191349 A1
申请人: SPIROGEN LTD
优先权: 2004
US
Ammonium Salts and Ammonium Salt/Mineral Salt Clathrate Compounds for Use as Vehicle and Effective Form for Pharmaco-Medical Applications and for Use as Phase Transfer Agents for Chemical Applications
US 2008317729 A1
申请人: KASCH HELMUT
优先权: 2004
US
Composition of ginkgo leaf extract and dipyridamole, medicine containing same and preparing method thereof
CN 1813782 B
申请人: XIAMEN GUOYU IP RES CO LTD
优先权: 2005
CN
PEPTIDES TARGETED TO PROTEIN KINASE C ISOFORMS AND USES THEREOF
US 2010041597 A1
申请人: PHIPPS JENNY
优先权: 2006
US
New heteocyclic H3 antagonists
CN 101795567 A
申请人: HIGH POINT PHARMACEUTICALS LLC
优先权: 2008
CN
Novel disulfonic acid type alkyl imidazole ionic liquid, preparation and uses thereof
CN 101508675 B
申请人: UNIV ZHEJIANG TECHNOLOGY
优先权: 2009
CN
第 1 / 2 页
上一页
下一页
药物
反馈
